Placeholder Banner

Media Advisory: NexSteppe CEO Anna Rath to Receive BIO Award Honoring an Outstanding Woman in Industrial Biotechnology

April 14, 2016

What:  President and CEO of NexSteppe Anna Rath will deliver remarks and will be presented the Rosalind Franklin Award by the Biotechnology Innovation Organization (BIO) at the 2016 World Congress on Industrial Biotechnology in San Diego on Tuesday April 19. The Rosalind Franklin Award is presented annually to honor an outstanding woman in the field of industrial biotechnology and bioprocessing.

Date:           Tuesday, April 19, 2016
Time:          12:00pm PST - 2:15pm PST
Who:           Anna Rath, President & CEO, NexSteppe
Location:    Ballroom 6AB
                    San Diego Convention Center
                    111 W Harbor Dr, San Diego, CA 92101

 

Background: A special selection committee of scientists and leaders in the field chose Rath for her commitment to the advancement of the field of industrial biotechnology.  In 2010, Anna Rath founded NexSteppe to develop and commercialize optimized crops for renewable energy and fuel. In fewer than five years, Anna built NexSteppe to a global team of over 40 people. NextSteppe’s unique technology platform has allowed it to become the leader in bioenergy sorghums, first in Brazil and now globally. Under Rath’s leadership, NexSteppe is laying a foundation for a sustainable and secure future for our economy, our environment, and our energy supply.

The Rosalind Franklin Society is the sponsor of the 2016 BIO Rosalind Franklin Award.

All programs at the World Congress on Industrial Biotechnology are open to attendance by members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.

For more information on the conference, please visit http://go.bio.org/WorldCongress2016.html. For assistance, please contact worldcongress@bio.org.

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.


 

    Discover More
    Washington, DC (December 2, 2020) - Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement regarding Nasdaq's filing with the Securities and Exchange Commission…
    Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
    "What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…